|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SONUS PHARMACEUTICALS INC, 10-Q, EX-10.42, 2000-08-14 |
Next: ELANTEC SEMICONDUCTOR INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 7,849,611
<SECURITIES> 9,494,433
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 17,698,465
<PP&E> 4,046,563
<DEPRECIATION> (3,396,614)
<TOTAL-ASSETS> 18,348,414
<CURRENT-LIABILITIES> 7,812,188
<BONDS> 0
0
0
<COMMON> 37,719,736
<OTHER-SE> (27,183,510)
<TOTAL-LIABILITY-AND-EQUITY> 18,348,414
<SALES> 0
<TOTAL-REVENUES> 44,969
<CGS> 0
<TOTAL-COSTS> 2,424,196
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (12,153)
<INCOME-PRETAX> 2,055,509
<INCOME-TAX> 0
<INCOME-CONTINUING> 2,055,509
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 2,055,509
<EPS-BASIC> 0.22
<EPS-DILUTED> 0.22
</TABLE>
|
|